Cost-effectiveness and budget impact of Empirical Vitamin D therapy on unintentional falls in older adults in the UK

BMJ Open

Volumn 5, Issue 9, 2015, Pages

  Poole, C D ^a   Smith, J ^b   Davies, J S ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b TORBAY HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; BONE DENSITY CONSERVATION AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; BUDGET; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; FALLING; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; QUALITY ADJUSTED LIFE YEAR; UNINTENTIONAL FALL; UNITED KINGDOM; VITAMIN SUPPLEMENTATION; COST BENEFIT ANALYSIS; DIETARY SUPPLEMENT; ECONOMICS; FEMALE; HEALTH INSURANCE; MALE; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ACCIDENTAL FALLS; AGED; BONE DENSITY CONSERVATION AGENTS; COST-BENEFIT ANALYSIS; DIETARY SUPPLEMENTS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; UNITED KINGDOM; VITAMIN D;

EID: 84956894684     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-007910     Document Type: Article

References (45)

1. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008;88:491S-9S.
2. Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 2013;12:976-89.
3. Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012;367:40-9.
4. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis. Lancet 2013;6736:1-10.
5. Vitamin D and falls. lancet Diabetes Endocrinol. http://apps.webofknowledge.com/full-record.do?product=UA&search-mode=GeneralSearch&qid=3&SID=X2nclIhxG5y5jkoL5B6&page=1&doc=1 (accessed 6 Sep 2014).
6. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ 2009;339:b3692.
7. Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society. Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011;59:148-57.
8. Davies SC, Jewell T, McBride M, et al. Vitamin d-advice on supplements for at risk groups. London: Department of Health, 2012. https://www.gov.uk/government/publications/vitamin-d-advice-onsupplements-for-at-risk-groups.
9. Lee RH, Weber T, Colón-Emeric C. Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults. J Am Geriatr Soc 2013;61:707-14.
10. Hiligsmann M, Ben Sedrine W, Bruyère O, et al. Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis. Eur J Public Health 2015;25:20-5.
11. Zarca K, Durand-Zaleski I, Roux C, et al. Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: A Markov micro-simulation model applied to the French population over 65years old without previous hip fracture. Osteoporos Int 2014;25:1797-806.
12. Poole CD, Smith JC, Davies JS. The short-term impact of vitamin D-based hip fracture prevention in older adults in the United Kingdom. J Endocrinol Invest 2014;37:811-17.
13. Scuffham P, Chaplin S, Legood R. Incidence and costs of unintentional falls in older people in the United Kingdom. J Epidemiol Community Heal 2003;57:740-4.
14. Office for National Statistics. Death Registrations Summary Tables- England and Wales, 2011 (Final). 2012. http://www.ons.gov.uk/ons/rel/vsob1/death-reg-sum-tables/2011-final-/index.html.
15. Bebbington A, Darton R, Netten A. Elderly people admitted to residential and nursing homes : 42 months on. 2000. http://www.pssru.ac.uk/pdf/p051.pdf.
16. US Preventive Services Task Force. Final Recommendation Statement: Vitamin D Deficiency: Screening. 2014. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/vitamin-d-deficiency-screening (accessed 1 Dec 2014).
17. MHRA. Off-label or unlicensed use of medicines: prescribers' responsibilities. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON087990 (accessed 14 Apr 2013).
18. British Medical Association, Royal Pharmaceutical Society. British National Formulary. 68th edn. London, UK: BMJ Publishing & Pharmaceutical Press, 2014. http://www.bnf.org.
19. HM Treasury. 2012 GDP deflators. 2012. http://www.hm-treasury.gov.uk/data-gdp-index.htm (accessed 29 Mar 2013).
20. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D (Discussion Paper 172). 1999.
21. Thiem U, Klaaßen-Mielke R, Trampisch U, et al. Falls and EQ-5D rated quality of life in community-dwelling seniors with concurrent chronic diseases: A cross-sectional study. Health Qual Life Outcomes 2014;12:2.
22. Couzner L, Crotty M, Norman R, et al. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population. Appl Health Econ Health Policy 2013;11:415-25.
23. Health & Social Care Information Centre. Hospital Episode Statistics, Admitted Patient Care, England-2012-13 [NS]. Leeds, UK: 2013. http://www.hscic.gov.uk/searchcatalogue?productid=13264&q=title:'Hospital+Episode+Statistics, +Admitted+patient+care+-+England'&sort=Relevance&size=10&page=1#top.
24. Office for National Statistics. Statistical bulletin: Annual Mid-year Population Estimates for England and Wales, 2012. http://www.ons.gov.uk/ons/rel/ppo-estimate/population-estimates-for-england-andwales/mid-2012/mid-2012-population-estimates-for-england-andwales.html#tab-background-notes.
25. Tinetti ME. Clinical practice. Preventing falls in elderly persons. N Engl J Med 2003;348:42-9.
26. Fuller GF. Falls in the elderly. Am Fam Physician 2000;61:2159-68, 2173-4.
27. Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11:1-160, iii- iv.
28. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860-8. http://www.ncbi.nlm.nih.gov/pubmed/17344510.
29. Zgaga L, Theodoratou E, Farrington SM, et al. Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient. J Nutr 2011;141:1535-42.
30. Girgis CM, Clifton-Bligh RJ, Turner N, et al. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 2014;80:169-81.
31. Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010;25:305-12.
32. Sanders KM, Scott D, Ebeling PR. Vitamin D deficiency and its role in muscle-bone interactions in the elderly. Curr Osteoporos Rep 2014;12:74-81.
33. Murad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: The effect of vitamin D on falls: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2997-3006.
34. Marcelli C, Chavoix C, Dargent-Molina P. Beneficial effects of vitamin D on falls and fractures: is cognition rather than bone or muscle behind these benefits? Osteoporos Int 2015;26:1-10.
35. Chalmers J, Conacher WD, Gardner DL, et al. Osteomalacia-a common disease in elderly women. J Bone Joint Surg Br 1967;49:403-23.
36. Diamond T, Wong YK, Golombick T. Effect of oral cholecalciferol 2, 000 versus 5, 000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 2013;24:1101-5.
37. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, et al. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: A randomized double-blind controlled trial. Ann Nutr Metab 2009;54:291-300.
38. Sinha A, Hollingsworth KG, Ball S, et al. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 2013;98:E509-13.
39. Rana P, Marwaha RK, Kumar P, et al. Effect of vitamin D supplementation on muscle energy phospho-metabolites: A (31)P magnetic resonance spectroscopy-based pilot study. Endocr Res2014;39:152-6.
40. Irani PF. Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 1976;39:686-93.
41. Ceglia L, Niramitmahapanya S, da Silva Morais M, et al. A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 2013;98:E1927-35.
42. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011;(7):CD007470.
43. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7.
44. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903.
45. Grant WB, Schwalfenberg GK, Genuis SJ, et al. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010;54:1172-81.